Trends in prevalence of chronic kidney disease in the United States

Annals of Internal Medicine

Volumn 165, Issue 7, 2016, Pages 473-481

  Murphy, Daniel ^a   McCulloch, Charles E ^b   Lin, Feng ^b   Banerjee, Tanushree ^c   Bragg Gresham, Jennifer L ^d   Eberhardt, Mark S ^a   Morgenstern, Hal ^d   Pavkov, Meda E ^e   Saran, Rajiv ^f   Powe, Neil R ^c   Hsu, Chi Yuan ^b  

^a NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

ADULT; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; ESTIMATED GLOMERULAR FILTRATION RATE; ETHNICITY; FEMALE; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL; RACE; UNITED STATES; AGED; BLOOD; CHRONIC KIDNEY FAILURE; GLOMERULUS FILTRATION RATE; MIDDLE AGED; NUTRITION; TIME FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; TIME FACTORS; UNITED STATES;

EID: 84990050539     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M16-0273     Document Type: Article

References (45)

1. United States Renal Data System. 2015 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. Bethesda, MD: National Institutes of Health; 2015. Accessed at www .usrds.org/2015/view/Default.aspx on 11 November 2015.
2. Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ. Chronic kidney disease: common, harmful, and treatable-World Kidney Day 2007. J Am Soc Nephrol. 2007;18:374-8. [PMID: 17229914]
3. Meguid El, Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet. 2005;365:331-40. [PMID: 15664230]
4. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038-47. [PMID: 17986697]
5. Grams ME, Juraschek SP, Selvin E, Foster MC, Inker LA, Eckfeldt JH, et al. Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates. Am J Kidney Dis. 2013;62:253-60. [PMID: 23619125] doi:10.1053/j .ajkd.2013.03.013
6. Hsu RK, Hsu CY. Temporal trends in prevalence of CKD: the glass is half full and not half empty [Editorial]. Am J Kidney Dis. 2013;62: 214-6. [PMID: 23883656] doi:10.1053/j.ajkd.2013.05.003
7. Hsu CY, Vittinghoff E, Lin F, Shlipak MG. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med. 2004;141:95-101. [PMID: 15262664] doi:10.7326/0003-4819-141-2-200407200-00007
8. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16:180-8. [PMID: 15563563]
9. Foley RN, Wang C, Snyder JJ, Collins AJ. Cystatin C levels in U.S. adults, 1988-1994 versus 1999-2002: NHANES. Clin J Am Soc Nephrol. 2009;4:965-72. [PMID: 19339409] doi:10.2215/CJN .05281008
10. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-305. [PMID: 15385656]
11. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260-72. [PMID: 23727169] doi:10.1016/S0140-6736(13) 60687-X
12. Hsu CY, Ordoñ ez JD, Chertow GM, Fan D, McCulloch CE, Go AS. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 2008;74:101-7. [PMID: 18385668] doi:10.1038 /ki.2008.107
13. Brück K, Stel VS, Gambaro G, Hallan S, Völzke H, Ärnlöv J, et al; European CKD Burden Consortium. CKD prevalence varies across the European general population. J Am Soc Nephrol. 2016;27:2134-47. [PMID: 26701975]
14. Healthy People 2020. Chronic Kidney Disease. Washington, DC: U.S. Department of Health and Human Services; 2016. Accessed at www.healthypeople.gov/2020/topics-objectives/topic/chronic-kidney-disease/objectives on 27 October 2015.
15. National Center for Health Statistics. National Health and Nutrition Examination Survey. Atlanta, GA: Centers for Disease Control and Prevention; 2016. Accessed at www.cdc.gov/nchs/nhanes.htm on 12 November 2015.
16. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-266. [PMID: 11904577]
17. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089-100. [PMID: 15882252]
18. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-12. [PMID: 19414839] doi:10.7326 /0003-4819-150-9-200905050-00006
19. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al; Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247-54. [PMID: 16908915] doi:10 .7326/0003-4819-145-4-200608150-00004
20. Saydah SH, Pavkov ME, Zhang C, Lacher DA, Eberhardt MS, Burrows NR, et al. Albuminuria prevalence in first morning void compared with previous random urine from adults in the National Health and Nutrition Examination Survey, 2009-2010. Clin Chem. 2013;59: 675-83. [PMID: 23315482] doi:10.1373/clinchem.2012.195644
21. 1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327-34. [PMID: 19502545] doi:10.2337 /dc09-9033
22. National Center for Health Statistics. National Health and Nutrition Examination Survey: Analytic Guidelines, 1999-2010. Washington, DC: US Gov Pr Office; 2013.
23. National Center for Health Statistics. National Health and Nutrition Examination Survey: Analytic Guidelines, 2011-2012. Atlanta, GA: Centers for Disease Control and Prevention; 2013. Accessed at www.cdc.gov/nchs/data/nhanes/analytic-guidelines-11-12.pdf on 5 December 2015.
24. Vittinghoff E, Glidden DG, Shiboski SC, McCulloch CE. Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models. 2nd ed. New York: Springer-Verlag; 2012:347-50.
25. Aitken GR, Roderick PJ, Fraser S, Mindell JS, O'Donoghue D, Day J, et al. Change in prevalence of chronic kidney disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010. BMJ Open. 2014;4:e005480. [PMID: 25270853] doi:10.1136/bmjopen-2014-005480
26. Hsu CY, Lin F, Vittinghoff E, Shlipak MG. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol. 2003;14:2902-7. [PMID: 14569100]
27. Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, et al; AASK and CRI Study Investigators. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med. 2013;369:2183-96. [PMID: 24206458] doi:10.1056/NEJMoa1310345
28. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305:2532-9. [PMID: 21693741] doi: 10.1001/jama.2011.861
29. Parving HH, Andersen AR, Smidt UM, Svendsen PA. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet. 1983;1:1175-9. [PMID: 6133986]
30. Tight blood pressure control and risk of macrovascular and mi-crovascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317:703-13. [PMID: 9732337]
31. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993;329:1456-62. [PMID: 8413456]
32. de Boer IH, Sun W, Cleary PA, Lachin JM, Molitch ME, Steffes MW, et al; DCCT/EDIC Research Group. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med. 2011; 365:2366-76. [PMID: 22077236] doi:10.1056/NEJMoa1111732
33. Finne P, Reunanen A, Stenman S, Groop PH, Grönhagen-Riska C. Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA. 2005;294:1782-7. [PMID: 16219881]
34. Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med. 2014;370:1514-23. [PMID: 24738668] doi:10.1056/NEJMoa1310799
35. Plantinga LC, Miller ER 3rd, Stevens LA, Saran R, Messer K, Flowers N, et al; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006. Hypertension. 2009;54:47-56. [PMID: 19470881] doi:10.1161/HYPERTENSIONAHA.109.129841
36. Gu Q, Paulose-Ram R, Dillon C, Burt V. Antihypertensive medication use among US adults with hypertension. Circulation. 2006; 113:213-21. [PMID: 16391156]
37. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010. Circulation. 2012;126:2105-14. [PMID: 23091084] doi:10.1161/CIRCULATIONAHA.112.096156
38. Yoon SS, Gu Q, Nwankwo T, Wright JD, Hong Y, Burt V. Trends in blood pressure among adults with hypertension: United States, 2003 to 2012. Hypertension. 2015;65:54-61. [PMID: 25399687] doi: 10.1161/HYPERTENSIONAHA.114.04012
39. Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999- 2010. Ann Intern Med. 2014;160:517-25. [PMID: 24733192] doi:10 .7326/M13-2411
40. Reule S, Sexton DJ, Solid CA, Chen SC, Foley RN. ESRD due to multiple myeloma in the United States, 2001-2010. J Am Soc Nephrol. 2016;27:1487-94. [PMID: 26516209] doi:10.1681/ASN .2014090876
41. 1C criteria in the U.S. population in 1988-2006. Diabetes Care. 2010;33: 562-8. [PMID: 20067953] doi:10.2337/dc09-1524
42. Selvin E, Manzi J, Stevens LA, Van Lente F, Lacher DA, Levey AS, et al. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis. 2007;50:918-26. [PMID: 18037092]
43. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol. 2000;11:155A.
44. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008;51:395-406. [PMID: 18295055] doi:10.1053/j.ajkd.2007.11.018
45. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al; CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012; 367:20-9. [PMID: 22762315] doi:10.1056/NEJMoa1114248